Home » Stocks » MASI

Masimo Corporation (MASI)

Stock Price: $275.18 USD 1.09 (0.40%)
Updated Aug 3, 2021 1:56 PM EDT - Market open
Market Cap 15.00B
Revenue (ttm) 1.18B
Net Income (ttm) 223.69M
Shares Out 55.03M
EPS (ttm) 3.86
PE Ratio 71.27
Forward PE 76.92
Dividend n/a
Dividend Yield n/a
Trading Day August 3
Last Price $275.18
Previous Close $274.09
Change ($) 1.09
Change (%) 0.40%
Day's Open 274.87
Day's Range 272.82 - 277.29
Day's Volume 98,490
52-Week Range 203.81 - 284.86

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Masimo's (MASI) robust product shipments, along with strong rebound in sensor sales, drive its Q2 sales.

6 days ago - Zacks Investment Research

Masimo (MASI) delivered earnings and revenue surprises of 3.30% and 2.92%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

6 days ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the second quarter of 2021, ended July 3, 2021. Second Quarter 2021 Results: Product revenue increased 1....

6 days ago - Business Wire

Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

Masimo's (MASI) latest offering is expected to improve patient care due to its re-engineered integration design.

2 weeks ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo announces the MX-7™ Technology Board, which supports all Masimo SET® and rainbow® parameters.

2 weeks ago - Business Wire

Health IT stocks like HealthEquity (HQY), Veeva Systems (VEEV), Tabula Rasa (TRHC) and Allscripts (MDRX) are expected to continue their run over the next few months.

Other stocks mentioned: ABC, HQY, MDRX, TRHC, VEEV
2 weeks ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release second quarter 2021 financial results for the period ended July 3, 2021, after the market closes on Tuesday, July 27, 2021. The confer...

2 weeks ago - Business Wire

Masimo (MASI) releases new study findings assessing two parameters provided by the SedLine that exhibit high predictability for mortality 180 days after cardiac arrest.

3 weeks ago - Zacks Investment Research

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study found that the combination of two Masimo SedLine® parameters had high predictability for mortality 180 days after cardiac arrest.

4 weeks ago - Business Wire

The stock price of Masimo Corporation, a medical devices company best known for its remote patient monitoring systems, has seen a rise of 9.4% in last twenty-one trading days, while it is up 14% over th...

1 month ago - Forbes

Masimo's (MASI) continuous, wearable thermometer is likely to help monitor and track body temperature in all thermometer applications following the FDA's clearance.

1 month ago - Zacks Investment Research

Masimo (NASDAQ: MASI) has announced that Radius Tº, a wearable, wireless thermometer, has received FDA 510(k) clearance for both prescription and over-the-counter (OTC) use on patients and consumers fiv...

1 month ago - Benzinga

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Radius Tº™, a wearable, wireless continuous body temperature thermometer, has received FDA 510(k) clearance for prescription and OTC use.

1 month ago - Business Wire

Masimo's (MASI) ORi-guided thoracic anesthesia procedure is likely to reduce hospital stay and increase patient safety.

1 month ago - Zacks Investment Research

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study found that oxygen titration guided by Masimo ORi™ may reduce hospital stay and increase patient safety.

1 month ago - Business Wire

Masimo (MASI) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021 at 2:00 ...

2 months ago - Business Wire

Masimo's (MASI) extension of partnership with Spacelabs is expected to provide better patient outcomes with the accessibility of patient monitoring solutions.

2 months ago - Zacks Investment Research

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A study evaluating Masimo Patient SafetyNet™ found that it reduced postoperative respiratory assessment nursing workload by more than 60%.

2 months ago - Business Wire

SNOQUALMIE, Wash.--(BUSINESS WIRE)--Spacelabs Healthcare and Masimo extend partnership to bring innovative patient monitors and advanced parameters to hospitals.

2 months ago - Business Wire

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study found that Masimo O3® Regional Oximetry may aid in monitoring septic shock patients and may have value as a predictor of mortality.

2 months ago - Business Wire

Here are the stocks seeing the most insider buying this week

YouTube video

Brian Sullivan's weekly segment on Worldwide Exchange brings you the top five stocks seeing the most insider buying action this week.

Other stocks mentioned: APH, ASB, LLY, ROK
2 months ago - CNBC Television

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo announced the findings of the first study to evaluate the utility of PVi® on patients treated with nasal high-flow therapy.

3 months ago - Business Wire

Masimo (MASI) continues to gain from its key Product segment, which makes a solid progress in Q1.

3 months ago - Zacks Investment Research

Masimo (MASI) delivered earnings and revenue surprises of 2.27% and 0.30%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of Masimo (NASDAQ:MASI) remain flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 7.22% year over year to $0.90, which beat the est...

3 months ago - Benzinga

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the first quarter of 2021, ended April 3, 2021. First Quarter 2021 Results: Product revenue increased 10....

3 months ago - Business Wire

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) has changed the date for the release of its first quarter 2021 financial results to Monday, April 26, 2021 due to executive scheduling changes. The...

3 months ago - Business Wire

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release first quarter 2021 financial results for the period ended April 3, 2021, after the market closes on Tuesday, April 27, 2021. The confe...

3 months ago - Business Wire

Investor optimism is high on Masimo (MASI) stock, courtesy of its solid prospects.

3 months ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Radius PCG™, a portable mainstream capnograph that connects wirelessly to the Root® Patient Monitoring Hub, has received FDA clearance.

3 months ago - Business Wire

Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.

Other stocks mentioned: CMD, HRC, LMAT, RMD
3 months ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the 20th Annual Needham Healthcare Conference on Monday, April 12, 2021 at 3:45 ...

3 months ago - Business Wire

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study investigating the impact of rescue therapies on the brains of patients with severe COVID-19 used Masimo O3® Regional Oximetry.

3 months ago - Business Wire

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study evaluated the accuracy of Masimo RRp® by comparing it to manual respiration rate counting on hospitalized, malnourished children.

4 months ago - Business Wire

Masimo (MASI) reported earnings 30 days ago. What's next for the stock?

4 months ago - Zacks Investment Research

The latest study highlights the efficacy of using Masimo's (MASI) SET pulse oximetry in screening CCHD in newborns.

4 months ago - Zacks Investment Research

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new CCHD screening study with Masimo SET® pulse oximetry recommended the implementation of pulse oximetry screening for all newborns in Sri Lanka.

4 months ago - Business Wire

The latest study highlights the importance of Masimo's (MASI) EMMA for children with tracheostomy, both in home-care settings and outpatient departments.

4 months ago - Zacks Investment Research

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study found the Masimo EMMA® Capnograph useful in the assessment of respiratory condition in children with tracheostomy.

4 months ago - Business Wire

According to the All-in-One Screener, a Premium feature of GuruFocus, four companies that have high profitability, business predictability and free cash flow growth are Autohome Inc. (NYSE:ATHM), Masimo...

Other stocks mentioned: ATHM, MPWR, SNPS
4 months ago - GuruFocus

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety, including SET® pulse oximetry.

4 months ago - Business Wire

These four MedTech stocks -- ABT, JNJ, MDT and MASI -- are expected to gain enormously from FDA's SaMD Action Plan 2021.

Other stocks mentioned: ABT, JNJ, MDT
4 months ago - Zacks Investment Research

Masimo's (MASI) Rad-G with Temperature, which aids clinicians in seamless assessment of key vital signs through a single device, gets CE marking.

4 months ago - Zacks Investment Research

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo Rad-G™ with Temperature, a rugged handheld device with SET® pulse oximetry, respiration rate, and temperature measurement, received CE marking.

5 months ago - Business Wire

Masimo (MASI) continues to gain from its key Product segment, which witnessed solid growth in Q4.

5 months ago - Zacks Investment Research

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Raymond James 42nd Annual Institutional Investors Conference on Wednesday, M...

5 months ago - Business Wire

Shares of Masimo (NASDAQ:MASI) fell  in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 7.69% year over year to $0.98, which beat the estimate ...

5 months ago - Benzinga

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended January 2, 2021. Fourth Quarter 2020 Results: Total revenue for th...

5 months ago - Business Wire

About MASI

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion ind... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Aug 8, 2007
CEO
Joseph Kiani
Employees
2,000
Stock Exchange
NASDAQ
Ticker Symbol
MASI
Full Company Profile

Financial Performance

In 2020, Masimo's revenue was $1.14 billion, an increase of 21.96% compared to the previous year's $937.84 million. Earnings were $240.30 million, an increase of 22.47%.

Financial Statements

Analyst Forecasts

According to 9 analysts, the average rating for Masimo stock is "Buy." The 12-month stock price forecast is 297.80, which is an increase of 8.22% from the latest price.

Price Target
$297.80
(8.22% upside)
Analyst Consensus: Buy